Shareholders have approved the sale of Coherus’s UDENYCA franchise to Intas Pharmaceuticals, a significant move in the company’s strategic shift towards focusing on oncology. The proceeds from ...

London-headquartered Accord is one of the largest suppliers of chemotherapy products in Europe and is a wholly-owned subsidiary of India's Intas Pharma, which has annual revenues of around $3.4 ...

with rumours swirling of a potential sale to longstanding partner Samsung Bioepis and a bid from Indian drugmaker Intas. More than a year after it was rejected by the FDA, Satsuma Pharma's ...

LUDHIANA: World Veterinary Day (WVD) was celebrated with great enthusiasm by Guru Angad Dev Veterinary and Animal Sciences ...

Preservative free cyclosporine is safe and effective for treating mild to moderate dry eye disease, a study shows.

EU & Emerging markets post signing the LOI by INTAS Pharmaceuticals as its fully owned subsidiary Sakar Healthcare Limited has informed the Exchange about Certificate under Regulation 74 (5) of the ...

Gujarat: Zydus Lifesciences has announced the appointment of Tushar Shroff as a President-Finance."This is to inform that ...

NASHVILLE, Tenn., April 29, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), a specialty pharmaceutical company, announced today that it will release its first quarter 2025 ...

The global cannabis use disorder treatment market is poised for strong growth, driven by rising cannabis consumption, the legalisation of cannabis for recreational and medicinal use, and increasing ...

WASHINGTON, April 30 (Reuters) - President Donald Trump said on Wednesday that there will be a tariff "wall" for pharmaceutical companies operating in the United States after a certain amount of time.

For the second year in a row, the pharmaceutical industry has dipped further out of favor with patient groups around the world. The industry’s reputation surged during the COVID-19 pandemic ...